References,Sample size,Interventions,Main race,Female (%),Mean HAMA,Mean age (Year),Attrition rate (%),Sponsor,Follow-up time (weeks),Diagnosis criteria
"Stein et al., 2017",412,agomelatine: 10 mg/day,NA,67.7,28.6,43.9,13.7,Institut de Recherches Internationales Servier (IRIS),12,dsm-iv-tr
"Stein et al., 2017",412,agomelatine: 25 mg/day,NA,67.7,29.0,44.1,9.4,Institut de Recherches Internationales Servier (IRIS),12,dsm-iv-tr
"Stein et al., 2017",412,placebo,NA,67.7,28.8,44.1,21.1,Institut de Recherches Internationales Servier (IRIS),12,dsm-iv-tr
